Clinical Trial Update: Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating concurrent use of Lymphoseek and Indocyanine Green for sentinel lymph node detection in endometrial cancer; study terminated with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)
• Lymphoseek (tilmanocept)

Snippet

Sponsor: Stanford University | Conditions: Endometrial Cancer | Phase 2 | Status: TERMINATED | Results posted: 2023-10-11